744206-31-3

744206-31-3 structure

Name: SD-6
Chemical Name: SD-6
CAS Number: 744206-31-3
Molecular Formula: C₂₀H₂₂N₄OS
Molecular Weight: 366.48
Catalog: Signaling Pathways Neuronal Signaling AChE
Create Date: 2023-06-28 12:01:09
Modify Date: 2024-01-27 06:15:40
SD-6 is an orally active inhibitor of hAChE and hBChE with IC50 values of 0.907 µM and 1.579 µM, respectively. SD-6 has excellent blood-brain barrier (BBB) permeability and no neurotoxicity, which can be used for research on Alzheimer's disease[1].

Name	SD-6

Description	SD-6 is an orally active inhibitor of hAChE and hBChE with IC50 values of 0.907 µM and 1.579 µM, respectively. SD-6 has excellent blood-brain barrier (BBB) permeability and no neurotoxicity, which can be used for research on Alzheimer's disease[1].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> Neuronal Signaling >> AChE
Target	hAChE:0.907 μM (IC50) hBCHE:1.579 μM (IC50)
In Vitro	SD-6 (5-80 µM；24 h) 在 SH-SY5Y 细胞中具有神经保护作用[1]。 Cell Viability Assay[1] Cell Line: SH-SY5Y cells. Concentration: 5, 10, 20, 40 or 80 µM. Incubation Time: 24 h. Result: Exhibited toxicity to differentiated SH-SY5Y cell lines and has a protective effect on undifferentiated SH-SY5Y cell lines.
In Vivo	SD-6 (100、300 和 500 mg/kg；口服；单剂量) 对未怀孕的雌性 Wistar 大鼠没有毒性作用[1]。 SD-6 (2.5、5 和 10 mg/kg；口服；一天 3 次，持续 7 天) 改善了东莨菪碱 (HY-N0296) 诱导的雄性 Wistar 大鼠认知和记忆缺陷[1]。 SD-6 (2.5、5 和 10 mg/kg；口服；单剂量) 显著改善了大鼠中东莨菪碱诱导的异常，促进生化指标正常化[1]。 Animal Model: 10–11 weeks nonpregnant female Wistar rats (220–280 g)[1]. Dosage: 100, 300 and 500 mg/kg. Administration: Oral gavage; single dose. Result: Showed safety and tolerability. Animal Model: 10–11 weeks male Wistar rats (220–280 g)[1]. Dosage: 2.5、5、10 mg/kg. Administration: Oral gavage; 3 times a day for 7 days or single dose. Result: Had the function of repairing cognitive and memory deficits. Reduced the level of AChE and malonaldehyde (MDA), increased the level of acetylcholine, superoxide dismutase (SOD), glutathione (GSH) and catalase.
References	[1]. Waiker DK, et al. Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer's Disease. ACS Omega. 2023 Mar 2;8(10):9394-9414.

Molecular Formula	C₂₀H₂₂N₄OS
Molecular Weight	366.48

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

77702-17-1	960201-81-4
33360-84-8	106300-05-4
4794-20-1	5836-04-4
14458-95-8	78448-45-0
1620-68-4	112430-78-1
1630848-03-1	1630837-11-4
1630872-36-4	1630862-52-0
1630848-42-8	1629766-10-4
1630848-07-5	1630907-86-6
1630862-64-4	2227649-11-6